Nomination committee proposes CMC specialist to Elicera’s board of directors
The Nomination Committee of Elicera Therapeutics AB (publ) proposes Sharon Longhurst as new board member. Sharon Longhurst is a specialist in CMC (Chemistry, Manufacturing and Control) and has solid experience for the development that is planned in Elicera. Elicera informed in a press release on October 31, 2023 that a Nomination Committee was formed ahead of the annual meeting on May 16, 2024. The Nomination Committee consists of Magnus Essand (chair), Di Yu and Jamal El-Mosleh, that together controlled 47.1 of the votes. The Nomination Committee has thus unanimously